| AGE | advanced glycosylation end products |
| BMS | burning mouth syndrome |
| D | type 2 iodothyronine deiodinase |
| DAG | diacylglycerol |
| DSHEA | Dietary Supplement Health and Education Act system |
| Epac | Exchange protein directly activated by cAMP |
| FBG | fasting blood glucose |
| FFAs | free fatty acids |
| FOSHU | Foods for Specialized Health Use |
| GDM | Gestational Diabetes Mellitus |
| GLP-1 | glucagon-like peptide-1 |
| TGR5 | G-protein-coupled bile acid receptor 5 |
| HFD | high fat diet |
| IKKb | b kinase inhibitor |
| IL | Interleukin |
| JNK | c-Jun-N-terminal kinases |
| LAB | lactic acid bacteria |
| LIP | liver inhibitory protein |
| LPL | lipoprotein lipase |
| LPS | lipopolysaccharides |
| MAPK | mitogen-activated protein kinase |
| PRRs | pattern recognition receptors |
| PYY | peptide tyrosine-tyrosine |
| SCFAs | Short-chain fatty acids |
| T1DM | type 1 diabetes mellitus |
| T2DM | type 2 diabetes mellitus |
| T3 | active tri-iodothyronine |
| TLR4 | Toll-like receptor 4 |
| TMA | trimethylamine |
| TNF | Tumor necrosis facto |
| VLDL | very low-density lipoproteins |
| WGS | Whole Genome Shotgun |
| XR | Farnesol X-receptor |